Results 81 to 90 of about 364 (156)

Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19. [PDF]

open access: yesInt J Mol Sci, 2021
Vilskersts R   +9 more
europepmc   +1 more source

The Effects of a Meldonium Pre-Treatment on the Course of the LPS-Induced Sepsis in Rats. [PDF]

open access: yesInt J Mol Sci, 2022
Đurašević S   +12 more
europepmc   +1 more source

Meldonium

open access: yesPractical Diabetes, 2016
openaire   +2 more sources

Impact myocardial cytoprotection and inotropic stimulation at the annual prognosis in patients with myocardial infarction lifting segment ST, complicated heart failure

open access: yesКардиоСоматика, 2015
The article analyzes the effectiveness and safety of treatment cytoprotectant meldonium dihydrate and inotropic stimulator of levosimendan on an annual prognosis in patients with myocardial infarction complicated by acute heart failure II-III class ...
M. N Sinkova   +5 more
doaj  

Two-component carnitine monooxygenase from Escherichia coli: functional characterization, inhibition and mutagenesis of the molecular interface. [PDF]

open access: yesBiosci Rep, 2022
Piskol F   +9 more
europepmc   +1 more source

Mildronate (meldonium): First, do no harm

open access: yes, 2020
Meldonium (Mildronate) is used as a cardioprotective drug; however, it has not been officially approved anywhere outside the former Soviet Union (SU). The supposed action mechanism is based on the carnitine (Lcarnitine) lowering effect in muscular and cardiac tissues.
openaire   +1 more source

The Effects of a Meldonium Pre-Treatment on the Course of the Faecal-Induced Sepsis in Rats. [PDF]

open access: yesInt J Mol Sci, 2021
Đurašević S   +12 more
europepmc   +1 more source

Dissociation between gut microbiota remodeling and early gut-liver injury in CLP-induced sepsis. [PDF]

open access: yesFront Pharmacol
Mašić T   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy